Analysis of intensity of free radical oxidation in non-alcoholic fatty liver disease with type 2 diabetes mellitus
I.P. Pavlov Russian Medical Biological Herald · 30.06.2026 · 34 (2) · 231-240
DOI: 10.17816/pavlovj656739 ↗Kurz gefasst
Fachartikel in der Zeitschrift I.P. Pavlov Russian Medical Biological Herald, online erschienen am 30.06.2026. Verfasst von Ekaterina A. Raskina und 4 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the leading pathology among chronic liver diseases. Lipid metabolism disorders and insulin resistance are considered to be mutually enhancing pathogenetic factors underlying the development of inflammation, oxidative stress and liver fibrosis. Ademetionine is a hepatoprotector that participates in synthesis of reduced glutathione and is capable of reducing the intensity of oxidative stress, inflammation and mitochondrial dysfunction. AIM: To conduct analyze the intensity of free radical oxidation, its association with clinical and biochemical parameters and the possibility of its reduction in the course of treatment with ademetionine in patients with NAFLD developing with type 2 diabetes mellitus (T2DM). METHODS: A single-center, prospective, non-randomized study included 35 patients aged 32–79 years with NAFLD and T2DM. The control group consisted of 65 practically healthy individuals aged 21–52 years. The activity of hepatocyte cytolysis marker enzymes, glycemic levels, and lipid profile were determined. Oxidative status was assessed using iron-induced biochemiluminescence (BCL), spectrophotometric determination of primary lipid peroxidation products: diene conjugates (DC), and enzyme-linked immunosorbent assay for 8-hydroxy-2-deoxyguanosine (8-OHdG) concentration. RESULTS: A strong and moderate correlation of glycemic levels and hepatocyte cytolysis markers with BCL parameters, DC and 8-OHdG concentrations was established (р 0.001). Standard therapy with ademetionine led to a decrease in glucose content and hepatocyte cytolysis parameters (р 0.001), and also to improvement of BCL parameters (р 0.01) and a decrease in DC concentrations in patients (р 0.001). Based on the results of ROC analysis, the DC and 8-OHdG levels were found to be reliable diagnostic criteria for liver damage in NAFLD with underlying T2DM: the area under the ROC curve was 0.948 and 0.957 respectively. CONCLUSIONS: Positive changes in the clinical and biochemical parameters of the development of pathology and of the intensity of oxidative stress observed in the course of treatment, were apparently associated with the ability of ademetionine to enhance glutathione biosynthesis, reduce the inflammatory response level and improve lipid metabolism in the liver of patients with NAFLD and T2DM.
Zitieren
APA
Raskina, E. A., Popov, S. S., Kryl'skii, E. D., Verevkin, A. N., & Popova, T. N. (2026). Analysis of intensity of free radical oxidation in non-alcoholic fatty liver disease with type 2 diabetes mellitus. I.P. Pavlov Russian Medical Biological Herald, 34(2), 231-240. https://doi.org/10.17816/pavlovj656739
Vancouver
Raskina EA, Popov SS, Kryl'skii ED, Verevkin AN, Popova TN. Analysis of intensity of free radical oxidation in non-alcoholic fatty liver disease with type 2 diabetes mellitus. I.P. Pavlov Russian Medical Biological Herald. 2026;34(2):231-240. doi:10.17816/pavlovj656739
BibTeX
@article{Raskina2026,
author = {Raskina, Ekaterina A. and Popov, Sergey S. and Kryl'skii, Evgenii D. and Verevkin, Aleksei N. and Popova, Tatyana N.},
title = {Analysis of intensity of free radical oxidation in non-alcoholic fatty liver disease with type 2 diabetes mellitus},
journal = {I.P. Pavlov Russian Medical Biological Herald},
year = {2026},
volume = {34},
number = {2},
pages = {231--240},
doi = {10.17816/pavlovj656739}
}
EUVIMED